{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:31:36Z","timestamp":1792701096875,"version":"4.5.0"},"reference-count":308,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jtos.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:13:11Z","timestamp":1684163591000},"page":"150-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-6406","authenticated-orcid":false,"given":"Danial","family":"Roshandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Semnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirmasoud","family":"Rayati Damavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Baradaran-Rafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-7387","authenticated-orcid":false,"given":"Samuel","family":"McLenachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICU.0000000000000378","article-title":"Limbal and corneal epithelial homeostasis","volume":"28","author":"Yazdanpanah","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1097-0029(19960301)33:4<296::AID-JEMT2>3.0.CO;2-O","article-title":"Conjunctiva","volume":"33","author":"Nichols","year":"1996","journal-title":"Microsc Res Tech"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.05.003_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajo.2020.12.019","article-title":"Ocular involvement in Sj\u00f6gren syndrome: risk factors for severe visual impairment and vision-threatening corneal complications","volume":"225","author":"Singh","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2022","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jtos.2023.05.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108455","article-title":"Systemic diseases and the cornea","volume":"204","author":"Shah","year":"2021","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/7759","article-title":"Identification of the gene responsible for gelatinous drop-like corneal dystrophy","volume":"21","author":"Tsujikawa","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2353\/ajpath.2010.100149","article-title":"Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy","volume":"177","author":"Nakatsukasa","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00003226-200007000-00029","article-title":"Epithelial barrier function and ultrastructure of gelatinous drop-like corneal dystrophy","volume":"19","author":"Kinoshita","year":"2000","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bjophthalmol-2016-309555","article-title":"Gelatinous drop-like corneal dystrophy: a review","volume":"101","author":"Kaza","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"10.1016\/j.jtos.2023.05.003_bib13","article-title":"Results of surgical procedures in gelatinous drop-like corneal dystrophy (GDCD) by scraping with\/without excimer laser phototherapeutic keratectomy (PTK)","volume":"44","author":"Yamaguchi","year":"2003","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00003226-200203000-00010","article-title":"Limbal stem cell transplantation for the treatment of subepithelial amyloidosis of the cornea (gelatinous drop-like dystrophy)","volume":"21","author":"Shimazaki","year":"2002","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10384-010-0879-9","article-title":"Simultaneous deep anterior lamellar keratoplasty and limbal allograft in bilateral limbal stem cell deficiency","volume":"54","author":"Omoto","year":"2010","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/OPX.0000000000000835","article-title":"Boston type 1 keratoprosthesis for gelatinous drop-like corneal dystrophy","volume":"93","author":"Lekhanont","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192381","article-title":"Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2023.05.003_bib18","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/ICO.0000000000001751","article-title":"Road to a genetic model of gelatinous drop-like corneal dystrophy","volume":"37","author":"Tsujikawa","year":"2018","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib19","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.ajpath.2020.08.017","article-title":"Corneal opacity induced by light in a mouse model of gelatinous drop-like corneal dystrophy","volume":"190","author":"Nagahara","year":"2020","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/tvst.7.6.30","article-title":"A new in vitro model of GDLD by knocking out TACSTD2 and its paralogous gene EpCAM in human corneal epithelial cells","volume":"7","author":"Xu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib21","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1167\/iovs.12-11043","article-title":"Establishment of a human corneal epithelial cell line lacking the functional TACSTD2 gene as an in vitro model for gelatinous drop-like dystrophy","volume":"54","author":"Kitazawa","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib22","first-page":"166","article-title":"Establishment of a human conjunctival epithelial cell line lacking the functional TACSTD2 gene (an American Ophthalmological Society thesis)","volume":"110","author":"Kinoshita","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"13","key":"10.1016\/j.jtos.2023.05.003_bib23","article-title":"Theoretical assessment for the gene therapy of gelatinous drop-like corneal dystrophy","volume":"55","author":"Kawasaki","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical administration of SLN-based gene therapy for the treatment of corneal inflammation by de novo IL-10 production","volume":"12","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0697-184","article-title":"Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy","volume":"16","author":"Irvine","year":"1997","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.jtos.2023.05.003_bib26","first-page":"2572","article-title":"Keratin 12-deficient mice have fragile corneal epithelia","volume":"37","author":"Kao","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0420.2007.00931.x","article-title":"Phenotypic variability in Meesmann's dystrophy: clinical review of the literature and presentation of a family genetically identical to the original family","volume":"86","author":"Ehlers","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bjo.84.5.527","article-title":"A novel keratin 12 mutation in a German kindred with Meesmann's corneal dystrophy","volume":"84","author":"Corden","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bjo.86.7.729","article-title":"A novel mutation in KRT12 associated with Meesmann's epithelial corneal dystrophy","volume":"86","author":"Irvine","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib30","doi-asserted-by":"crossref","first-page":"E1202","DOI":"10.1097\/OPX.0b013e3181baad27","article-title":"Management of symptomatic Meesmann dystrophy","volume":"86","author":"Jalbert","year":"2009","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00003226-199809000-00017","article-title":"Recurrent Meesmann's corneal epithelial dystrophy after penetrating keratoplasty","volume":"17","author":"Chiou","year":"1998","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000506435","article-title":"Identification of a novel missense KRT12 mutation in a Vietnamese family with Meesmann corneal dystrophy","volume":"11","author":"Dong","year":"2020","journal-title":"Case Rep Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/ICO.0000000000002620","article-title":"Coexistence of Meesmann corneal dystrophy and a pseudo-unilateral lattice corneal dystrophy in a patient with a novel pathogenic variant in the keratin K3 gene: a case report","volume":"40","author":"Abad-Morales","year":"2021","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/hmg\/ddw001","article-title":"Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophy","volume":"25","author":"Allen","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028582","article-title":"Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy","volume":"6","author":"Liao","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1167\/iovs.12-10528","article-title":"Allele-specific siRNA silencing for the common keratin 12 founder mutation in Meesmann epithelial corneal dystrophy","volume":"54","author":"Allen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib37","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1167\/iovs.13-12957","article-title":"siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophy","volume":"55","author":"Courtney","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/gt.2015.82","article-title":"CRISPR\/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting","volume":"23","author":"Courtney","year":"2016","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib39","first-page":"397","article-title":"Familial occurrence of dot (microcystic), map, fingerprint dystrophy of the cornea","volume":"14","author":"Laibson","year":"1975","journal-title":"Invest Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/humu.20331","article-title":"A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI\/BIGH3","volume":"27","author":"Boutboul","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtos.2023.05.003_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100843","article-title":"Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies","volume":"77","author":"Nielsen","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/humu.22764","article-title":"Mutations in collagen, type XVII, alpha 1 (COL17A1) cause epithelial recurrent erosion dystrophy (ERED)","volume":"36","author":"Jonsson","year":"2015","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157418","article-title":"Whole exome sequencing and segregation analysis confirms that a mutation in COL17A1 is the cause of epithelial recurrent erosion dystrophy in a large dominant pedigree previously mapped to chromosome 10q23-q24","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ophtha.2015.12.008","article-title":"A COL17A1 splice-altering mutation is prevalent in inherited recurrent corneal erosions","volume":"123","author":"Oliver","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/ICO.0000000000001619","article-title":"Epithelial recurrent erosion dystrophy secondary to COL17A1 c.3156C>T mutation in a non-white family","volume":"37","author":"Vahedi","year":"2018","journal-title":"Cornea"},{"issue":"13","key":"10.1016\/j.jtos.2023.05.003_bib46","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1167\/iovs.16-19818","article-title":"Genotype-phenotype correlation for TGFBI corneal dystrophies identifies p.(G623D) as a novel cause of epithelial basement membrane dystrophy","volume":"57","author":"Evans","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib47","first-page":"198","article-title":"Uncovering the profile of mutations of transforming growth factor beta-induced gene in Chinese corneal dystrophy patients","volume":"9","author":"Hao","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jcp.1041600314","article-title":"cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium","volume":"160","author":"Escribano","year":"1994","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib49","first-page":"656","article-title":"Molecular properties of wild-type and mutant betaIG-H3 proteins","volume":"43","author":"Kim","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/febs.14321","article-title":"Proteomic profiling of TGFBI-null mouse corneas reveals only minor changes in matrix composition supportive of TGFBI knockdown as therapy against TGFBI-linked corneal dystrophies","volume":"285","author":"Poulsen","year":"2018","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib51","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41598-020-58876-w","article-title":"Generation of mouse model of TGFBI-R124C corneal dystrophy using CRISPR\/Cas9-mediated homology-directed repair","volume":"10","author":"Kitamoto","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133397","article-title":"Development of a transgenic mouse with R124H human TGFBI mutation associated with granular corneal dystrophy type 2","volume":"10","author":"Yamazoe","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3892\/ijmm.2013.1480","article-title":"Establishment of a transgenic mouse model of corneal dystrophy overexpressing human BIGH3","volume":"32","author":"Liao","year":"2013","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/17469899.2016.1152182","article-title":"Congenital aniridia: etiology, manifestations and management","volume":"11","author":"Samant","year":"2016","journal-title":"Expet Rev Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ajmg.a.32209","article-title":"Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia","volume":"146a","author":"Robinson","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1542-0124(12)70130-1","article-title":"Keratopathy in congenital aniridia","volume":"1","author":"Mayer","year":"2003","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib57","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.biocel.2004.09.002","article-title":"Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy","volume":"37","author":"Ramaesh","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0161-6420(02)01451-3","article-title":"Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique","volume":"110","author":"Holland","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-015-0009-1","article-title":"Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series","volume":"6","author":"Bobba","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib60","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/TP.0b013e3181a4bbf2","article-title":"A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction","volume":"87","author":"Di Girolamo","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jtos.2023.05.003_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/281870","article-title":"Cultivated oral mucosa epithelium in ocular surface reconstruction in aniridia patients","volume":"2015","author":"Dobrowolski","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtos.2023.05.003_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2019.11.003","article-title":"Management of congenital aniridia-associated keratopathy: long-term outcomes from a tertiary referral center","volume":"210","author":"Yazdanpanah","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib63","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/stem.2343","article-title":"Correction of mutant p63 in EEC syndrome using siRNA mediated allele-specific silencing restores defective stem cell function","volume":"34","author":"Barbaro","year":"2016","journal-title":"Stem Cell"},{"key":"10.1016\/j.jtos.2023.05.003_bib64","article-title":"Long-term anatomical and functional survival of boston type 1 keratoprosthesis in congenital aniridia","volume":"8","author":"Dyer","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib65","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2015.03.025","article-title":"Boston keratoprosthesis: outcomes and complications: a report by the American academy of ophthalmology","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ceo.12663","article-title":"Use of topical retinoic acid for limbal stem cell failure: a retrospective clinical case series","volume":"44","author":"Chew","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib67","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1167\/iovs.02-0576","article-title":"Corneal abnormalities in Pax6+\/- small eye mice mimic human aniridia-related keratopathy","volume":"44","author":"Ramaesh","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41434-018-0043-6","article-title":"Epistasis between Pax6(Sey) and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials","volume":"25","author":"Hickmott","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtos.2023.05.003_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102184","article-title":"Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6","volume":"51","author":"Harding","year":"2021","journal-title":"Stem Cell Res"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/genes10121050","article-title":"The spectrum of PAX6 mutations and genotype-phenotype correlations in the eye","volume":"10","author":"Lima Cunha","year":"2019","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib71","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.2858","article-title":"Modeling of aniridia-related keratopathy by CRISPR\/Cas9 genome editing of human limbal epithelial cells and rescue by recombinant PAX6 protein","volume":"36","author":"Roux","year":"2018","journal-title":"Stem Cell"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib72","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1002\/mgg3.1198","article-title":"Nonsense suppression induced readthrough of a novel PAX6 mutation in patient-derived cells of congenital aniridia","volume":"8","author":"Liu","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jtos.2023.05.003_bib73","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtm.2020.03.002","article-title":"Germline CRISPR\/Cas9-Mediated gene editing prevents vision loss in a novel mouse model of aniridia","volume":"17","author":"Mirjalili Mohanna","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib74","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1399-0004.1972.tb01473.x","article-title":"Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome","volume":"3","author":"Fried","year":"1972","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib75","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/ajmg.a.35414","article-title":"A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: implications for recurrence risk and prenatal diagnosis","volume":"158a","author":"Barbaro","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/341450","article-title":"Splitting p63","volume":"71","author":"van Bokhoven","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ophtha.2011.06.044","article-title":"Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutations","volume":"119","author":"Di Iorio","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib78","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1046\/j.1523-1747.2002.19526.x","article-title":"Common mutations in Arg304 of the p63 gene in ectrodactyly, ectodermal dysplasia, clefting syndrome: lack of genotype-phenotype correlation and implications for mutation detection strategies","volume":"119","author":"Hamada","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/hmg\/11.7.799","article-title":"Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63","volume":"11","author":"Duijf","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib80","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/323123","article-title":"p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation","volume":"69","author":"van Bokhoven","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib81","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.5966\/sctm.2015-0358","article-title":"Personalized stem cell therapy to correct corneal defects due to a unique homozygous-heterozygous mosaicism of ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"5","author":"Barbaro","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib82","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0161-6420(85)33847-2","article-title":"Keratopathy in a family with the ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"92","author":"Mawhorter","year":"1985","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10792-012-9585-6","article-title":"Corneal changes in ectrodactyly-ectodermal dysplasia-cleft lip and palate syndrome: case series and literature review","volume":"32","author":"Felipe","year":"2012","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib84","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002341-199807000-00014","article-title":"Ophthalmic manifestations of ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"14","author":"Ireland","year":"1998","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib85","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9394(14)76134-3","article-title":"Absent meibomian glands in the ectrodactyly, ectodermal dysplasia, cleft lip-palate syndrome","volume":"97","author":"Mondino","year":"1984","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib86","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s10384-003-0076-1","article-title":"Increased tear evaporation in a patient with ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"48","author":"Matsumoto","year":"2004","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib87","doi-asserted-by":"crossref","first-page":"E795","DOI":"10.1097\/OPX.0b013e31818527cd","article-title":"Management of evaporative dry eye in ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"85","author":"Ota","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib88","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jtos.2019.01.010","article-title":"Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation","volume":"17","author":"Cortina","year":"2019","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.survophthal.2014.10.001","article-title":"Retinoic acid and the ocular surface","volume":"60","author":"Samarawickrama","year":"2015","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib90","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.1201753109","article-title":"Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246\/PRIMA-1MET","volume":"110","author":"Shalom-Feuerstein","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2023.05.003_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.scr.2018.02.008","article-title":"Induced pluripotent stem cells line (UNIPDi003-A) from a patient affected by EEC syndrome carrying the R279H mutation in TP63 gene","volume":"28","author":"Trevisan","year":"2018","journal-title":"Stem Cell Res"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cell.2017.0064","article-title":"Oral mucosa-derived induced pluripotent stem cells from patients with ectrodactyly-ectodermal dysplasia-clefting syndrome","volume":"20","author":"Trevisan","year":"2018","journal-title":"Cell Reprogr"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-80-2-221","article-title":"Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair","volume":"80","author":"Robbins","year":"1974","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib94","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.dnarep.2008.01.014","article-title":"Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy","volume":"7","author":"Kleijer","year":"2008","journal-title":"DNA Repair"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib95","first-page":"1135","article-title":"Genetics and skin cancer of xeroderma pigmentosum in Japan","volume":"78","author":"Takebe","year":"1987","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib96","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bjd.14046","article-title":"Clinical, genealogical and molecular investigation of the xeroderma pigmentosum type C complementation group in Tunisia","volume":"174","author":"Jerbi","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.2004.06311.x","article-title":"Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study","volume":"152","author":"Bhutto","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jmg.23.1.72","article-title":"Sensitivity to ultraviolet radiation in a dominantly inherited form of xeroderma pigmentosum","volume":"23","author":"Imray","year":"1986","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/ICO.0000000000002499","article-title":"Ocular features in a large cohort of Indians with xeroderma pigmentosum","volume":"40","author":"Nandyala","year":"2021","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib100","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.ophtha.2017.04.031","article-title":"Ophthalmic manifestations of xeroderma pigmentosum: a perspective from the United Kingdom","volume":"124","author":"Lim","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer","year":"1987","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib102","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ophtha.2012.12.044","article-title":"Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage","volume":"120","author":"Brooks","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2023.05.003_bib103","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-2-5","article-title":"Xeroderma pigmentosum: an updated review","volume":"11","author":"Leung","year":"2022","journal-title":"Drugs Context"},{"key":"10.1016\/j.jtos.2023.05.003_bib104","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.921301","article-title":"Effect of pegylated interferon and mitomycin C on ocular surface squamous neoplasia in xeroderma pigmentosum: a case series","volume":"21","author":"Dirar","year":"2020","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010713","article-title":"The management of ocular surface squamous neoplasia (OSSN)","volume":"24","author":"Yeoh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib106","article-title":"Management of coexisting bilateral ocular surface disease in xeroderma pigmentosum - sequence and outcomes","author":"Rajagopal","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.003_bib107","article-title":"Type I keratoprosthesis for visual rehabilitation of patients with xeroderma pigmentosum","volume":"2014","author":"Ummar","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"6545","key":"10.1016\/j.jtos.2023.05.003_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/377165a0","article-title":"High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene","volume":"377","author":"Nakane","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib109","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jid.2017.04.034","article-title":"CXCL1 inhibition regulates UVB-induced skin inflammation and tumorigenesis in Xpa-deficient mice","volume":"137","author":"Kunisada","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2220\/biomedres.41.237","article-title":"Autophagy induction on impaired spermatogenesis of xeroderma pigmentosum group A gene-deficient mice","volume":"41","author":"Nakane","year":"2020","journal-title":"Biomed Res"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020630","article-title":"Drosophila as a model organism to understand the effects during development of TFIIH-related human diseases","volume":"21","author":"Zurita","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib112","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/cell.2014.0104","article-title":"Generation of xeroderma pigmentosum-A patient-derived induced pluripotent stem cell line for use as future disease model","volume":"17","author":"Ohnishi","year":"2015","journal-title":"Cell Reprogr"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032050","article-title":"IKAP\/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration","volume":"7","author":"Hunnicutt","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib114","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-0004.1987.tb03334.x","article-title":"Incidence of familial dysautonomia in Israel 1977-1981","volume":"32","author":"Maayan","year":"1987","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/109065703322146830","article-title":"Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews","volume":"7","author":"Lehavi","year":"2003","journal-title":"Genet Test"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib116","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/318808","article-title":"Familial dysautonomia is caused by mutations of the IKAP gene","volume":"68","author":"Anderson","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib117","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/302339","article-title":"Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31","volume":"64","author":"Blumenfeld","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/ped.12538","article-title":"Hereditary sensory and autonomic neuropathy types IV and V in Japan","volume":"57","author":"Haga","year":"2015","journal-title":"Pediatr Int"},{"issue":"Pt A","key":"10.1016\/j.jtos.2023.05.003_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4615-0717-8_9","article-title":"Familial dysautonomia in review: diagnosis and treatment of ocular manifestations","volume":"506","author":"Josaitis","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2023.05.003_bib120","first-page":"95","article-title":"Riley-Day syndrome: long-term ophthalmologic observations","volume":"66","author":"Liebman","year":"1968","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib121","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/02713680802450992","article-title":"In vivo confocal microscopy of hereditary sensory and autonomic neuropathy","volume":"33","author":"Mimura","year":"2008","journal-title":"Curr Eye Res"},{"issue":"18","key":"10.1016\/j.jtos.2023.05.003_bib122","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1517\/14656566.2014.970530","article-title":"Current treatments in familial dysautonomia","volume":"15","author":"Palma","year":"2014","journal-title":"Expet Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib123","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0002-9394(79)90404-5","article-title":"Corneal transplantation in familial dysautonomia","volume":"88","author":"Karpik","year":"1979","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib124","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10286-017-0438-2","article-title":"Animal and cellular models of familial dysautonomia","volume":"27","author":"Lefcort","year":"2017","journal-title":"Clin Auton Res"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/1678-4685-gmb-2015-0335","article-title":"Familial dysautonomia: mechanisms and models","volume":"39","author":"Dietrich","year":"2016","journal-title":"Genet Mol Biol"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib126","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/nar\/gky249","article-title":"Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice","volume":"46","author":"Sinha","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib127","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.ajhg.2022.07.004","article-title":"Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA","volume":"109","author":"Romano","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib128","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41467-021-24705-5","article-title":"Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia","volume":"12","author":"Ajiro","year":"2021","journal-title":"Nat Commun"},{"issue":"Pt A","key":"10.1016\/j.jtos.2023.05.003_bib129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/978-1-4615-0717-8_89","article-title":"Enzymatic mechanisms in corneal ulceration with specific reference to familial dysautonomia: potential for genetic approaches","volume":"506","author":"Fini","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","article-title":"Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry","volume":"152","author":"Fine","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib131","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib132","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajo.2004.03.034","article-title":"Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry","volume":"138","author":"Fine","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib133","first-page":"1277","article-title":"Eye involvement and management in inherited epidermolysis bullosa","volume":"82","author":"Bachir","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib134","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985819900354","article-title":"Spontaneous KRT5 gene mutation in Rhesus Macaques (Macaca mulatta): a novel nonhuman primate model of epidermolysis bullosa simplex","volume":"57","author":"Johnson","year":"2020","journal-title":"Vet Pathol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/sctm.17-0182","article-title":"Efficacy of human placental-derived stem cells in collagen VII knockout (recessive dystrophic epidermolysis bullosa) animal model","volume":"7","author":"Liao","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib136","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048082","article-title":"Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease","volume":"14","author":"Smith","year":"2021","journal-title":"Dis Model Mech"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib137","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.det.2009.10.016","article-title":"Animal models of epidermolysis bullosa","volume":"28","author":"Natsuga","year":"2010","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib138","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jid.2022.04.009","article-title":"Human-induced pluripotent stem cell\u2012derived keratinocytes, a useful model to identify and explore the pathological phenotype of epidermolysis bullosa simplex","volume":"142","author":"Coutier","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"22","key":"10.1016\/j.jtos.2023.05.003_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212222","article-title":"Therapeutic prospects of exon skipping for epidermolysis bullosa","volume":"22","author":"Vermeer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.jtos.2023.05.003_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207705","article-title":"Nonsequential splicing events alter antisense-mediated exon skipping outcome in COL7A1","volume":"21","author":"Ham","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073326","article-title":"Personalized development of antisense oligonucleotides for exon skipping restores type XVII collagen expression in junctional epidermolysis bullosa","volume":"22","author":"Ablinger","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib142","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jid.2020.08.018","article-title":"QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study","volume":"141","author":"Bornert","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib143","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"issue":"7680","key":"10.1016\/j.jtos.2023.05.003_bib144","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13023-022-02546-9","article-title":"Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa","volume":"17","author":"So","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtos.2023.05.003_bib146","article-title":"COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa","volume":"9","author":"Petkovi\u0107","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24184-8","article-title":"ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation","volume":"12","author":"Sheriff","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib148","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.ymthe.2022.06.005","article-title":"Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa","volume":"30","author":"Hong","year":"2022","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13816810.2017.1408849","article-title":"Diagnosis of multiple endocrine neoplasia type 2B and management of its ocular features","volume":"39","author":"Kreps","year":"2018","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib151","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ophtha.2004.07.034","article-title":"Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome","volume":"112","author":"Messmer","year":"2005","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib152","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0000000000001802","article-title":"Ocular surface stem cell transplantation for treatment of keratitis-ichthyosis-deafness syndrome","volume":"38","author":"Cheung","year":"2019","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib153","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/ICO.0000000000001387","article-title":"Severe phenotype of keratitis-ichthyosis-deafness syndrome with presumed ocular surface squamous neoplasia","volume":"37","author":"Serrano-Ahumada","year":"2018","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib154","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jid.2019.09.022","article-title":"Allele-specific small interfering RNA corrects aberrant cellular phenotype in keratitis-ichthyosis-deafness syndrome keratinocytes","volume":"140","author":"Lee","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pbc.21960","article-title":"Dyskeratosis congenita with corneal limbal insufficiency","volume":"53","author":"Aslan","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib156","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.exer.2009.12.008","article-title":"Dyskeratosis congenita and limbal stem cell deficiency","volume":"90","author":"Aslan","year":"2010","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib157","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10792-012-9611-8","article-title":"Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita","volume":"32","author":"Aslan","year":"2012","journal-title":"Int Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib158","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tips.2020.05.003","article-title":"Small molecules restore telomeres in patient stem cells","volume":"41","author":"Brenner","year":"2020","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib159","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08164622.2021.1971047","article-title":"Keeping an 'eye' on ocular GVHD","volume":"105","author":"Kezic","year":"2022","journal-title":"Clin Exp Optom"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib160","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A review of ocular graft-versus-host disease: pathophysiology, clinical presentation and management","volume":"29","author":"Carreno-Galeano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064724","article-title":"Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease","volume":"8","author":"Yaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2023.05.003_bib162","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1639012","article-title":"Reduced expression of VAMP8 in lacrimal gland affected by chronic graft-versus-host disease","volume":"2017","author":"Fukui","year":"2017","journal-title":"J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib163","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1167\/iovs.15-16736","article-title":"Gene expression-based predictive models of graft versus host disease-associated dry eye","volume":"56","author":"Cocho","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib164","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtos.2023.05.003_bib165","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3389\/fimmu.2018.03104","article-title":"BET bromodomain inhibitors which permit Treg function enable a combinatorial strategy to suppress GVHD in pre-clinical allogeneic HSCT","volume":"9","author":"Copsel","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib166","article-title":"Immunomodulatory gene therapy for treatment of ocular graft vs host disease","volume":"62","author":"Nilles","year":"2021","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib167","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.13383","article-title":"Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Antoon","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jtos.2023.05.003_bib168","first-page":"287","article-title":"Whole-exome sequencing in patients affected by Stevens-Johnson syndrome and toxic epidermal necrolysis reveals new variants potentially contributing to the phenotype","volume":"14","author":"Fonseca","year":"2021","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.jtos.2023.05.003_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.912478","article-title":"Susceptibility genes and HLA for cold medicine-related SJS\/TEN with SOC","volume":"13","author":"Ueta","year":"2022","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib170","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2014.12.1916","article-title":"IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe mucosal involvement","volume":"135","author":"Ueta","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 11","key":"10.1016\/j.jtos.2023.05.003_bib171","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/ICO.0000000000000605","article-title":"Genetic predisposition to Stevens-Johnson syndrome with severe ocular surface complications","volume":"34","author":"Ueta","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2023.05.003_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114931","article-title":"Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome","volume":"658","author":"Chomean","year":"2022","journal-title":"Anal Biochem"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib173","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/0018578720934972","article-title":"Clinical utility of HLA-B*58:01 genotyping to prevent allopurinol-induced SJS\/TEN","volume":"56","author":"Lavu","year":"2021","journal-title":"Hosp Pharm"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib174","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","article-title":"Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment","volume":"23","author":"Ahmed","year":"2004","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib175","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib176","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/jovr.jovr_86_18","article-title":"Ocular manifestations and management of autoimmune bullous diseases","volume":"14","author":"Feizi","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib177","first-page":"3379","article-title":"Ocular cicatricial pemphigoid (Review)","volume":"20","author":"Branisteanu","year":"2020","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib178","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC Class II genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib179","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/exd.13464","article-title":"Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid","volume":"26","author":"Sadik","year":"2017","journal-title":"Exp Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2023.05.003_bib180","first-page":"A1","article-title":"OP-1 Conjunctival genetic 'fingerprinting' in ocular mucous membrane pemphigoid","volume":"7","author":"Panthagani","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib181","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1346-8138.12447","article-title":"Ocular involvement in pemphigus vulgaris","volume":"41","author":"Akhyani","year":"2014","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib182","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/OPX.0b013e31821ddef3","article-title":"Conjunctival erosions associated with pemphigus vulgaris","volume":"88","author":"Brackley","year":"2011","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901386","article-title":"Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population","volume":"13","author":"Drenovska","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib184","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol"},{"issue":"19","key":"10.1016\/j.jtos.2023.05.003_bib185","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib186","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib187","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.humimm.2012.02.001","article-title":"Tumor necrosis factor-\u03b1 -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus","volume":"73","author":"Mosaad","year":"2012","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib188","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.2005.06882.x","article-title":"Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris","volume":"154","author":"Capon","year":"2006","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib189","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/jid.2012.46","article-title":"Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris","volume":"132","author":"Sarig","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clindermatol.2016.05.021","article-title":"Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms","volume":"35","author":"Tanasilovic","year":"2017","journal-title":"Clin Dermatol"},{"issue":"6295","key":"10.1016\/j.jtos.2023.05.003_bib191","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jtos.2023.05.003_bib192","article-title":"Milestones in personalized medicine in pemphigus and pemphigoid","volume":"11","author":"Bieber","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib193","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5114\/ada.2020.96167","article-title":"Ocular manifestations of dermal paraneoplastic syndromes","volume":"37","author":"Zdebik","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jtos.2023.05.003_bib194","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib196","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib197","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaut.2005.03.006","article-title":"Genetic factors in pemphigus","volume":"24","author":"Tron","year":"2005","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib198","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2133.1988.tb02593.x","article-title":"A comparative serological and molecular study of linear IgA disease and dermatitis herpetiformis","volume":"118","author":"Sachs","year":"1988","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib199","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2340\/0001555563123128","article-title":"Linear IgA dermatosis: a study of ten adult patients","volume":"63","author":"Mobacken","year":"1983","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib200","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-2133.1999.03110.x","article-title":"Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression","volume":"141","author":"Collier","year":"1999","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/life11101012","article-title":"Understanding vernal keratoconjunctivitis: beyond allergic mechanisms","volume":"11","author":"Sacchetti","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jtos.2023.05.003_bib202","first-page":"37","article-title":"La cheratocongiuntivite vernal","volume":"2","author":"Pucci","year":"2007","journal-title":"Rivista di Immunologia e Allergologia Pediatrica"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13052-021-01073-w","article-title":"Vernal keratoconjunctivitis in twins: case report and literature review","volume":"47","author":"Artesani","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jtos.2023.05.003_bib204","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.847168","article-title":"MicroRNA profiling of the tears of children with vernal keratoconjunctivitis","volume":"13","author":"Syed","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jtos.2023.05.003_bib205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtos.2020.09.009","article-title":"Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis","volume":"19","author":"Leonardi","year":"2021","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib206","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/ICO.0000000000001832","article-title":"Thymic stromal lymphopoietin-related allergic pathway in patients with vernal keratoconjunctivitis","volume":"38","author":"Zhang","year":"2019","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib207","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2500\/aap.2013.34.3612","article-title":"Atopic keratoconjunctivitis","volume":"34","author":"Sy","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib208","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1398-9995.2008.01781.x","article-title":"Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis","volume":"63","author":"Dogru","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jtos.2023.05.003_bib209","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9914786","article-title":"Alterations in mucin-associated gene expression on the ocular surface in active and stable stages of atopic and vernal keratoconjunctivitis","volume":"2021","author":"Horinaka","year":"2021","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib210","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2018.11.007","article-title":"Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing","volume":"143","author":"Matsuda","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib211","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/ACI.0000000000000555","article-title":"Neurotrophic factors and nerve growth factor in ocular allergy","volume":"19","author":"Sacchetti","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1167\/iovs.09-4183","article-title":"Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis","volume":"51","author":"Matsuda","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib213","first-page":"192","article-title":"Chemokine receptor gene expression in giant papillae of atopic keratoconjunctivitis","volume":"11","author":"Yamagami","year":"2005","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib214","first-page":"252","article-title":"Peripheral ulcerative keratitis: a review","volume":"17","author":"Hassanpour","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2023.05.003_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108458","article-title":"Biology of peripheral ulcerative keratitis","volume":"204","author":"Gomes","year":"2021","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib216","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","article-title":"Peripheral ulcerative keratitis","volume":"66","author":"Gupta","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib217","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bjo.2007.127050","article-title":"HLA-DR17 and Mooren's ulcer in South India","volume":"92","author":"Zelefsky","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib218","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1998.4681","article-title":"Cytokine-induced calgranulin C expression in keratocytes","volume":"91","author":"Gottsch","year":"1999","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib219","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.ico.0000214216.75496.7e","article-title":"Mooren ulcer: an immunopathologic study","volume":"25","author":"Kafkala","year":"2006","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00417-016-3516-6","article-title":"Upregulation of NLRP3 inflammasome components in Mooren's ulcer","volume":"255","author":"Li","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib221","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.18240\/ijo.2021.11.03","article-title":"Increased cGAS\/STING signaling components in patients with Mooren's ulcer","volume":"14","author":"Zhang","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib222","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/ICO.0b013e31820357e2","article-title":"Clinicopathological features of a suspected case of hereditary benign intraepithelial dyskeratosis with bilateral corneas involved: a case report and mini review","volume":"30","author":"Cai","year":"2011","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib223","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/318194","article-title":"A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis","volume":"68","author":"Allingham","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib224","first-page":"76","article-title":"Hereditary benign intraepithelial dyskeratosis: report of a case and Re-examination of the evidence for locus heterogeneity","volume":"37","author":"Bui","year":"2016","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jmedgenet-2012-101325","article-title":"Whole exome sequencing identifies a mutation for a novel form of corneal intraepithelial dyskeratosis","volume":"50","author":"Soler","year":"2013","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e3181924ec3","article-title":"Conjunctival\/corneal intraepithelial neoplasia","volume":"49","author":"Hamam","year":"2009","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib227","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/bjo.2005.077305","article-title":"The aetiology and associations of conjunctival intraepithelial neoplasia","volume":"90","author":"Kiire","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib228","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cdp.2005.08.003","article-title":"TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda","volume":"29","author":"Tornesello","year":"2005","journal-title":"Cancer Detect Prev"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib229","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/pin.13147","article-title":"Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance","volume":"71","author":"Shiba-Ishii","year":"2021","journal-title":"Pathol Int"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib230","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1111\/aos.14844","article-title":"Stratifin in ocular surface squamous neoplasia and its association with p53","volume":"99","author":"Chauhan","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib231","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2015-307503","article-title":"TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis","volume":"100","author":"Lin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib232","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1120672119858225","article-title":"Vitamin D receptor gene polymorphisms in ocular surface squamous cell neoplasms","volume":"30","author":"Ismayilova","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.003_bib233","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6875996","article-title":"Vitamin D receptor gene polymorphisms and the risk of CIN2+ in Shanxi population","volume":"2022","author":"Li","year":"2022","journal-title":"BioMed Res Int"},{"issue":"95","key":"10.1016\/j.jtos.2023.05.003_bib234","first-page":"52","article-title":"Squamous cell carcinoma of the conjunctiva","volume":"29","author":"Gichuhi","year":"2016","journal-title":"Community Eye Health"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archopht.1975.01010020125005","article-title":"Invasive squamous cell carcinoma of the conjunctiva","volume":"93","author":"Iliff","year":"1975","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib236","first-page":"109","article-title":"Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes--the 2017 J. Donald M. Gass lecture","volume":"6","author":"Shields","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib237","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jtos.2020.07.011","article-title":"Whole exome profiling and mutational analysis of ocular surface squamous neoplasia","volume":"18","author":"Ramos-Betancourt","year":"2020","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib238","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1167\/iovs.14-14920","article-title":"Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma","volume":"55","author":"Asnaghi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib239","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.oftal.2022.02.005","article-title":"OVOL1 immunohistochemical expression is a useful tool to diagnose invasion in ocular surface squamous neoplasms","volume":"97","author":"Ter\u00e1n","year":"2022","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib240","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjophthalmol-2017-311276","article-title":"p16(INK4a) overexpression as a predictor of survival in ocular surface squamous neoplasia","volume":"102","author":"Chauhan","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.003_bib241","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijbiomac.2021.11.120","article-title":"Functional impact of titin (TTN) mutations in ocular surface squamous neoplasia","volume":"195","author":"Djulbegovic","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jtos.2023.05.003_bib242","first-page":"2263","article-title":"S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue","volume":"17","author":"Li","year":"2011","journal-title":"Mol Vis"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib243","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.2016.41","article-title":"Altered gene expression in conjunctival squamous cell carcinoma","volume":"29","author":"Mahale","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib244","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2353\/ajpath.2008.070700","article-title":"Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma","volume":"172","author":"McCarty","year":"2008","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.11.7.23","article-title":"The use of panitumumab-IRDye800CW in a novel murine model for conjunctival squamous cell carcinoma","volume":"11","author":"Youn","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib246","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.4103\/ijo.IJO_2040_19","article-title":"Tumors of the conjunctiva and cornea","volume":"67","author":"Shields","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib247","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2004.02.013","article-title":"Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors","volume":"111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib248","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1167\/iovs.04-1449","article-title":"T1799A BRAF mutations in conjunctival melanocytic lesions","volume":"46","author":"Goldenberg-Cohen","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib249","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.17-22517","article-title":"BRAF, NRAS, and GNAQ mutations in conjunctival melanocytic nevi","volume":"59","author":"Francis","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib250","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2019-314807","article-title":"Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions","volume":"104","author":"\u0160ekoranja","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib251","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2015.3200","article-title":"A retrospective review of conjunctival melanoma presentation, treatment, and outcome and an investigation of features associated with BRAF mutations","volume":"133","author":"Larsen","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib252","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/aos.13007","article-title":"BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib253","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","article-title":"BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma","volume":"15","author":"Patton","year":"2005","journal-title":"Curr Biol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib254","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/13816810.2020.1810281","article-title":"Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings","volume":"41","author":"McGrath","year":"2020","journal-title":"Ophthalmic Genet"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jamaophthalmol.2013.129","article-title":"Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes","volume":"131","author":"Shields","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib256","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000495508","article-title":"GNAQ and PMS1 mutations associated with uveal melanoma, ocular surface melanosis, and nevus of Ota","volume":"5","author":"Toomey","year":"2019","journal-title":"Ocul Oncol Pathol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib257","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pcmr.12452","article-title":"Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations","volume":"29","author":"Vivancos","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7229","key":"10.1016\/j.jtos.2023.05.003_bib258","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib259","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004051","article-title":"Genomic evolution of uveal melanoma arising in ocular melanocytosis","volume":"5","author":"Durante","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib260","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/13816810.2019.1650073","article-title":"Clinical and genetic characteristics of nevus of Ota with choroidal melanoma in Chinese","volume":"40","author":"Pan","year":"2019","journal-title":"Ophthalmic Genet"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib261","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0046-8177(86)80175-7","article-title":"Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior","volume":"17","author":"Folberg","year":"1986","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib262","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0046-8177(85)80062-9","article-title":"Malignant melanoma of the conjunctiva","volume":"16","author":"Folberg","year":"1985","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib263","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ophtha.2007.07.003","article-title":"Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture","volume":"115","author":"Shields","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib264","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","article-title":"Conjunctival melanoma","volume":"42","author":"Seregard","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib265","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1167\/iovs.14-14901","article-title":"Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions","volume":"55","author":"Koopmans","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2023.05.003_bib266","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1111\/aos.12166","article-title":"C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions","volume":"91","author":"Alessandrini","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib267","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/apm.12529","article-title":"Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey","volume":"124","author":"Mikkelsen","year":"2016","journal-title":"Apmis"},{"key":"10.1016\/j.jtos.2023.05.003_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib269","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","article-title":"Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","article-title":"Conjunctival melanoma in The Netherlands: a nationwide study","volume":"46","author":"Missotten","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100971","article-title":"Conjunctival melanoma: new insights in tumour genetics and immunology, leading to new therapeutic options","volume":"86","author":"Brouwer","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib272","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41416-018-0046-5","article-title":"NF1 mutations in conjunctival melanoma","volume":"118","author":"Scholz","year":"2018","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib273","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib274","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bjophthalmol-2014-305730","article-title":"Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients","volume":"99","author":"Sheng","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"21","key":"10.1016\/j.jtos.2023.05.003_bib275","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.jtos.2023.05.003_bib276","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.16-19862","article-title":"MicroRNA expression profile in conjunctival melanoma","volume":"57","author":"Larsen","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib277","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ophtha.2019.10.008","article-title":"MicroRNA profiling in benign and malignant conjunctival melanocytic lesions","volume":"127","author":"van Ipenburg","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2023.05.003_bib278","article-title":"Systemic treatment of metastatic conjunctival melanoma","volume":"2017","author":"Pinto Torres","year":"2017","journal-title":"Case Rep Oncol Med"},{"issue":"22","key":"10.1016\/j.jtos.2023.05.003_bib279","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1158\/1078-0432.CCR-13-2007","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations--Letter","volume":"19","author":"Weber","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.jtos.2023.05.003_bib280","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1158\/1078-0432.CCR-13-2368","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations--response","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtos.2023.05.003_bib281","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fonc.2019.00232","article-title":"Dabrafenib and trametinib in BRAF mutant metastatic conjunctival melanoma","volume":"9","author":"Rossi","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib282","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/IOP.0000000000000833","article-title":"Conjunctival melanoma responsive to combined systemic BRAF\/MEK inhibitors","volume":"33","author":"Dagi Glass","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib283","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42358-022-00255-2","article-title":"Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome","volume":"62","author":"de Oliveira","year":"2022","journal-title":"Adv Rheumatol"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib284","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib285","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12016-022-08951-z","article-title":"A summary on the genetics of systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and sj\u00f6gren\u2019s syndrome","volume":"64","author":"Ort\u00edz-Fern\u00e1ndez","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"23","key":"10.1016\/j.jtos.2023.05.003_bib286","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315239","article-title":"Tear proteomics approach to distinguishing primary from secondary Sj\u00f6gren's syndrome for dry eye patients with long-term instillation of eyedrops","volume":"23","author":"Hsiao","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2023.05.003_bib287","first-page":"837","article-title":"Genetic and clinical basis for two distinct subtypes of primary Sj\u00f6gren's syndrome","volume":"60","author":"Thorlacius","year":"2021","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib288","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00439-016-1716-0","article-title":"Identification of susceptibility gene associated with female primary Sj\u00f6gren's syndrome in Han Chinese by genome-wide association study","volume":"135","author":"Song","year":"2016","journal-title":"Hum Genet"},{"issue":"11","key":"10.1016\/j.jtos.2023.05.003_bib289","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren's syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat Genet"},{"issue":"11s","key":"10.1016\/j.jtos.2023.05.003_bib290","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ophtha.2017.07.022","article-title":"Update in current diagnostics and therapeutics of dry eye disease","volume":"124","author":"Thulasi","year":"2017","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.jtos.2023.05.003_bib291","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3346\/jkms.2016.31.7.1127","article-title":"Effect of hydroxychloroquine treatment on dry eyes in subjects with primary Sj\u00f6gren's syndrome: a double-blind randomized control study","volume":"31","author":"Yoon","year":"2016","journal-title":"J Kor Med Sci"},{"issue":"22","key":"10.1016\/j.jtos.2023.05.003_bib292","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214135","article-title":"The future of targeted treatment of primary Sj\u00f6gren's syndrome: a focus on extra-glandular pathology","volume":"23","author":"Zeng","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib293","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/art.41489","article-title":"Improvement of severe fatigue following nuclease therapy in patients with primary Sj\u00f6gren's syndrome: a randomized clinical trial","volume":"73","author":"Posada","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.jtos.2023.05.003_bib294","first-page":"2398","article-title":"Experimental models of Sj\u00f6gren\u2019s syndrome: differences and similarities with human disease","volume":"40","author":"Kaklamanos","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.exer.2008.05.019","article-title":"MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients","volume":"88","author":"Imbert","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.05.003_bib296","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.12659\/MSM.915434","article-title":"Association between single nucleotide polymorphisms in the vitamin D receptor and incidence of dry eye disease in Chinese han population","volume":"25","author":"Meng","year":"2019","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib297","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2023.05.003_bib298","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ahg.12340","article-title":"Shared gene signature between pterygium and meibomian gland dysfunction uncovered through gene-expression meta-analysis","volume":"83","author":"Zhang","year":"2019","journal-title":"Ann Hum Genet"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib299","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1167\/iovs.10-6482","article-title":"Changes in gene expression in human meibomian gland dysfunction","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2023.05.003_bib300","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1002\/jcb.28742","article-title":"Prediction of potential drugs and targets based on meibomian gland dysfunction module classification to guide individualized treatment","volume":"120","author":"Ni","year":"2019","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib301","doi-asserted-by":"crossref","first-page":"635","DOI":"10.18240\/ijo.2022.04.18","article-title":"Transgenic dry eye mouse models: powerful tools to study dry eye disease","volume":"15","author":"Qin","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"22","key":"10.1016\/j.jtos.2023.05.003_bib302","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228822","article-title":"Meibomian gland dysfunction: what have animal models taught us?","volume":"21","author":"Sun","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2023.05.003_bib303","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747357","article-title":"Genetic modification of limbal stem cells to decrease allogeneic immune responses","volume":"12","author":"Valdivia","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jtos.2023.05.003_bib304","doi-asserted-by":"crossref","first-page":"e2227","DOI":"10.1038\/cddis.2016.118","article-title":"Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity","volume":"7","author":"Novelli","year":"2016","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib305","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtos.2023.05.003_bib306","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U","article-title":"A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response","volume":"80","author":"Abdel-Wahab","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jtos.2023.05.003_bib307","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/mt.2013.275","article-title":"Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sj\u00f6gren's syndrome as a proof of concept","volume":"22","author":"Roescher","year":"2014","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.jtos.2023.05.003_bib308","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21374-2","article-title":"Correction of LAMP3-associated salivary gland hypofunction by aquaporin gene therapy","volume":"12","author":"Nakamura","year":"2022","journal-title":"Sci Rep"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T23:22:28Z","timestamp":1716420148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012423000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":308,"alternative-id":["S1542012423000459"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2023.05.003","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}